Human pDCs preferentially sense enveloped hepatitis A virions

Journal of Clinical Investigation

Volumn 125, Issue 1, 2015, Pages 169-176

  Feng, Zongdi ^a,c   Li, You ^a   McKnight, Kevin L ^a   Hensley, Lucinda ^a   Lanford, Robert E ^b   Walker, Christopher M ^c,d   Lemon, Stanley M ^a,e  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b SOUTHWEST NATIONAL PRIMATE RESEARCH CENTER   (United States)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

^d THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; ALPHA INTERFERON; PHOSPHATIDYLSERINE; TOLL LIKE RECEPTOR 7; VIRUS RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL STIMULATION; CHIMPANZEE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; EXOSOME; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PROTEIN INDUCTION; RHESUS MONKEY; SIGNAL TRANSDUCTION; VIRION; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS REPLICATION; ANIMAL; CELL CULTURE; COCULTURE; DENDRITIC CELL; IMMUNOLOGY; LIVER; METABOLISM; PAN TROGLODYTES; TUMOR CELL LINE; VIROLOGY;

ANIMALS; CELL LINE, TUMOR; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; HEPATITIS A; HEPATITIS A VIRUS, HUMAN; HUMANS; INTERFERON-ALPHA; LIVER; PAN TROGLODYTES; VIRION;

EID: 84920377377     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI77527     Document Type: Article

References (47)

1. Gilliet M, Cao W, Liu YJ. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol. 2008;8(8):594-606.
2. Reizis B, Bunin A, Ghosh HS, Lewis KL, Sisirak V. Plasmacytoid dendritic cells: recent progress and open questions. Annu Rev Immunol. 2011;29:163-183.
3. Cervantes-Barragan L, et al. Plasmacytoid dendritic cells control T-cell response to chronic viral infection. Proc Natl Acad Sci U S A. 2012;109(8):3012-3017.
4. Deal EM, Lahl K, Narvaez CF, Butcher EC, Greenberg HB. Plasmacytoid dendritic cells promote rotavirus-induced human and murine B cell responses. J Clin Invest. 2013;123(6):2464-2474.
5. Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med. 2003;198(3):513-520.
6. Hornung V, et al. Replication-dependent potent IFN-α induction in human plasmacytoid dendritic cells by a single-stranded RNA virus. J Immunol. 2004;173(10):5935-5943.
7. Feldman SB, Ferraro M, Zheng HM, Patel N, Gould-Fogerite S, Fitzgerald-Bocarsly P. Viral induction of low frequency interferon-alpha producing cells. Virology. 1994;204(1):1-7.
8. Pritchard AL, Carroll ML, Burel JG, White OJ, Phipps S, Upham JW. Innate IFNs and plasma-cytoid dendritic cells constrain Th2 cytokine responses to rhinovirus: a regulatory mech-anism with relevance to asthma. J Immunol. 2012;188(12):5898-5905.
9. Guzylack-Piriou L, Bergamin F, Gerber M, McCullough KC, Summerfield A. Plasmacytoid dendritic cell activation by foot-and-mouth disease virus requires immune complexes. Eur J Immunol. 2006;36(7):1674-1683.
10. Wang JP, Asher DR, Chan M, Kurt-Jones EA, Finberg RW. Cutting edge: antibody-mediated TLR7-dependent recognition of viral RNA. J Immunol. 2007;178(6):3363-3367.
11. Feng Z, et al. A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature. 2013;496(7445):367-371.
12. Lanford RE, et al. Acute hepatitis A virus infection is associated with a limited type I interferon response and persistence of intra-hepatic viral RNA. Proc Natl Acad Sci U S A. 2011;108(27):11223-11228.
13. Martin A, Lemon SM. Hepatitis A virus: from discovery to vaccines. Hepatology. 2006; 43(2):S164-SS72.
14. Qu L, et al. Disruption of TLR3 signaling due to cleavage of TRIF by the hepatitis A virus protease-polymerase processing intermediate, 3CD. PLoS Pathog. 2011;7(9):e1002169.
15. Yang Y, et al. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc Natl Acad Sci U S A. 2007;104(17):7253-7258.
16. Meylan E, et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature. 2005;437(7062):1167-1172.
17. Li K, et al. and Lemon SM. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the TLR3 adaptor protein TRIF. Proc Natl Acad Sci U S A. 2005;102(8):2992-2997.
18. Su AI, et al. Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci U S A. 2002;99(24):15669-15674.
19. Bigger CB, et al. Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. J Virol. 2004;78(24):13779-13792.
20. Sarasin-Filipowicz M, et al. Interferon signaling and treatment outcome in chronic hepatitis C. Proc Natl Acad Sci U S A. 2008;105(19):7034-7039.
21. Takahashi K, et al. Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, inhibit infection. Proc Natl Acad Sci U S A. 2010;107(16):7431-7436.
22. Dreux M, et al. Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host Microbe. 2012;12(4):558-570.
23. Jansen RW, Newbold JE, Lemon SM. Complete nucleotide sequence of a cell culture-adapted variant of hepatitis A virus: comparison with wild-type virus with restricted capacity for in vitro replication. Virology. 1988;163(2):299-307.
24. Feigelstock D, Thompson P, Mattoo P, Zhang Y, Kaplan GG. The human homolog of HAVcr-1 codes for a hepatitis A virus cellular receptor. J Virol. 1998;72(8):6621-6628.
25. Cantin R, Diou J, Belanger D, Tremblay AM, Gilbert C. Discrimination between exosomes and HIV-1: purification of both vesicles from cell-free supernatants. J Immunol Methods. 2008;338(1):21-30.
26. Asea A, et al. Heat shock protein-containing exo-somes in mid-trimester amniotic fluids. J Reprod Immunol. 2008;79(1):12-17.
27. Bissig C, Gruenberg J. ALIX and the multivesicu-lar endosome: ALIX in Wonderland. Trends Cell Biol. 2014;24(1):19-25.
28. Moller-Tank S, Kondratowicz AS, Davey RA, Ren-nert PD, Maury W. Role of the phosphatidylser-ine receptor TIM-1 in enveloped-virus entry. J Virol. 2013;87(15):8327-8341.
29. Morizono K, et al. The soluble serum protein Gas6 bridges virion envelope phosphatidylserine to the TAM receptor tyrosine kinase Axl to mediate viral entry. Cell Host Microbe. 2011;9(4):286-298.
30. Xiao S, et al. Tim-1 stimulation of dendritic cells regulates the balance between effector and regulatory T cells. Eur J Immunol. 2011;41(6):1539-1549.
31. Malcolm BA, et al. Peptide aldehyde inhibitors of hepatitis A virus 3C proteinase. Biochemistry. 1995;34(25):8172-8179.
32. Mercer J, Helenius A. Virus entry by macropino-cytosis. Nat Cell Biol. 2009;11(5):510-520.
33. Strauss M, Levy HC, Bostina M, Filman DJ, Hogle JM. RNA transfer from poliovirus 135S particles across membranes is mediated by long umbilical connectors. J Virol. 2013;87(7):3903-3914.
34. Wang X, et al. Hepatitis A virus and the origins of picornaviruses [published online ahead of print October 19, 2014]. Nature. doi:10.1038/nature13806.
35. Lee HK, Lund JM, Ramanathan B, Mizushima N, Iwasaki A. Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science. 2007;315(5817):1398-1401.
36. Swiecki M, Wang Y, Vermi W, Gilfillan S, Schreiber RD, Colonna M. Type I interferon neg-atively controls plasmacytoid dendritic cell numbers in vivo. J Exp Med. 2011;208(12):2367-2374.
37. Thomas JM, et al. Differential responses of plasmacytoid dendritic cells to influenza virus and distinct viral pathogens. J Virol. 2014;88(18):10758-10766.
38. Welsh RM, Bahl K, Marshall HD, Urban SL. Type 1 interferons and antiviral CD8 T-cell responses. PLoS Pathog. 2012;8(1):e1002352.
39. Wilson EB, Brooks DG. Decoding the complexity of type I interferon to treat persistent viral infections. Trends Microbiol. 2013;21(12):634-640.
40. Zhou Y, et al. Dominance of the CD4(+) T helper cell response during acute resolving hepatitis A virus infection. J Exp Med. 2012;209(8):1481-1492.
41. Odorizzi PM, Wherry EJ. Immunology. An interferon paradox. Science. 2013;340(6129):155-156.
42. Lau DT, et al. Interferon regulatory factor-3 activation, hepatic interferon-stimulated gene expression, and immune cell infiltration in hepatitis C virus patients. Hepatology. 2008;47(3):799-809.
43. Velazquez VM, Hon H, Ibegbu C, Knechtle SJ, Kirk AD, Grakoui A. Hepatic enrichment and activation of myeloid dendritic cells during chronic hepatitis C virus infection. Hepatology. 2012;56(6):2071-2081.
44. Bergmann EM, et al. Crystal structure of an inhibitor complex of the 3C proteinase from hepatitis A virus (HAV) and implications for the polyprotein processing in HAV. Virology. 1999;265(1):153-163.
45. Li G, et al. Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice. PLoS Pathog. 2014;10(7):e1004291.
46. Blight KJ, McKeating JA, Rice CM. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol. 2002;76(24):13001-13014.
47. Hopps HE, Bernheim BC, Nisalak A, Tjio JH, Smadel JE. Biologic characteristics of a continuous kidney cell line derived from the African green monkey. J Immunol. 1963;91:416-424.